The increased number of joint prostheses now being implanted into younger and more active patients has made wear and tear on polyethylene bearing surfaces more apparent and more important. Many papers have described the measurement of wear rate, mainly in the hip, and also the biological consequences of the tissue response to polyethylene particles liberated by wear. There is now good evidence that these particles accumulate in periprosthetic tissues, cause an inflammatory reaction, and lead to bone lysis. Implant loosening made worse by severe bone loss presents the surgeon with a difficult task of revision, and this is becoming a major problem in limiting the life of joint replacements. The level of interest in this ‘UHMWPE disease’ (Sedel 1992) can be gauged from the presentation of more than 50 polyethylene-related papers at the 1996 Orthopaedic Research Society meeting in Atlanta. Research into the problem of wear is complex, since ultra-high-molecular-weight polyethylene (UHMWPE) is variable in its manufactured state. This material was chosen because polyethylene has little biological and chemical reactivity and its high molecular weight imparts resistance to wear. The manufacture of implants of this polymer is difficult. Many of the normal processes, such as injection moulding, break down the long-chain molecules of UHMWPE and make it more liable to wear. The polymer is available as a base powder, which could be used to mould implants, but the cost and difficulties of this process mean that most of the manufacturers of implants obtain their stock as sheets or bars from specialist companies such as Hoechst. The prosthetic components are then machined from this solid stock. It is possible for manufacturers to modify UHMWPE by subjecting it to elevated pressures and temperatures, but as yet there is no evidence that this leads to reduced wear in clinical use. Orthopaedic implants use much less than 1% of the world production of UHMWPE, with the result that there is little implant-related commercial pressure on the polymer producers. Indeed, concern about litigation is causing polymer manufacturers to consider withdrawal from the field. Thus, changes may be made in a polymer without the knowledge of the end user or the manufacturer of the prosthesis. The material is still UHMWPE, but minor changes in the catalyst or the fusion process at fabrication can lead to changes in the final product. These may alter the wear or degradation resistance of prostheses, and make it almost impossible to perform valid comparative tests between implants, and very difficult to verify claimed advances in polymer quality. Li and Wright (1995) have recently offered